Phase 2 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand what the study involves and are willing to sign a consent form.
- You are male or female, aged between 18 and 70 years old at the time of signing the consent form.
- Your body weight is between 40 and 90 kg (approximately 88 to 198 lbs).
- You have been diagnosed with lupus (SLE) by a doctor at least 6 months before the screening visit, confirmed using standard medical classification guidelines.
- At screening, you have either a specific blood marker called ANA at a level of 1:80 or higher, or a positive result for another lupus-related antibody called anti-dsDNA (confirm with trial site if unsure which applies to you).
- Your lupus disease activity score (measured by a tool called SLEDAI-2K) meets a minimum threshold at both the screening and baseline visits, indicating your lupus is currently active enough to qualify.
- You are currently taking at least one standard lupus medication, such as a steroid tablet, an antimalarial drug, or an immunosuppressant.
Who may not be able to join:
- You have been diagnosed with mixed connective tissue disease or an overlap of lupus with a condition called systemic sclerosis.
- You have a medical or mental health condition — including certain lupus-related brain or nervous system complications — that the study doctor believes could make it unsafe or difficult for you to take part, including any life-threatening condition.
- You currently have an active Hepatitis B, Hepatitis C, or HIV infection, as shown by a positive test at screening.
- You have a history of cancer.
- You have had a severe, active form of lupus affecting the kidneys in the 2 months before the baseline visit, or your kidney function or protein levels in urine fall outside the acceptable range for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18911301578
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.